Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (2): 233-239    DOI: 10.31083/j.ejgo.2020.02.5099
Original Research Previous articles | Next articles
Lifestyle with particular emphasis on physical activity and genital carcinomas in women
K. Plagens–Rotman1, *(), M. Piskorz–Szymendera1, B. PIĘTA1
1 Department of Mother's and Child's Health, University of Medical Sciences, Poznań, Poland
Download:  PDF(616KB)  ( 270 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Positive effects of physical activity on the reduction of the risk of chronic diseases such as cardiovascular diseases, diabetes, hypertension, but primarily to reduce the risk of breast, colorectal and endometrial cancer. The aim of the study was to determine the effect of physical activity on the risk of developing cancer of female reproductive organs. The study involved women with ovarian, cervical, and endometrial cancer (diagnosed on the basis of histopathological evidence) and healthy controls. A total number of 953 women (aged 21 to 84 years) was included. Moderate (600 - 1500 MET) and vigorous (> 1500 MET) physical activity during household chores reduces the risk of ovarian cancer (OC). The odds ratio of developing OC is OR = 0.35; 95% Cl 0.09 – 1.31 and OR = 0.23; 95% Cl 0.07 – 0.80, as compared to women with low physical activity  (< 600 MET). The respondents who reported engaging in sports activities between 600 and 1500 MET/day have a lower risk of cervical cancer, OR = 0.52; 95% Cl 0.19 – 1.46.  In order to reduce the risk of malignant neoplasia in female reproductive organs, physical effort of 600 - 1500 MET should be undertaken.
Key words:  Ovarian cancer      Cervical cancer      Endometrial cancer      Physical activity      Lifestyle      Disease odds ratio     
Published:  15 April 2020     
*Corresponding Author(s):  K. PLAGENS–ROTMAN     E-mail:  plagens.rotman@gmail.com

Cite this article: 

K. Plagens–Rotman, M. Piskorz–Szymendera, B. PIĘTA. Lifestyle with particular emphasis on physical activity and genital carcinomas in women. European Journal of Gynaecological Oncology, 2020, 41(2): 233-239.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.02.5099     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I2/233

[1] Ikuji Shimazaki, Yasunori Hashiguchi, Makoto Yamauchi, Mari Kasai, Takeshi Fukuda, Tomoyuki Ichimura, Tomoyo Yasui, Toshiyuki Sumi. Secondary small cell vaginal cancer after operative therapy for endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 821-823.
[2] Yu Hui Lim, Sheow Lei Lim, Linda Xiao Hui Lin, Lay Tin Soh, Hoon Seng Khoo Tan, Richard Ming Chert Yeo, Timothy Yong Kuei Lim. Sequential Chemoradiation versus Radiation for the Adjuvant Treatment of Stage III Endometrioid Adenocarcinoma of the Uterus[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 705-712.
[3] Eda Kucuktulu, Ahmet Fatih Yurekli. Simultaneous Integrated Intensity Modulated Radiotherapy Boost for Gynecological Cancer when Brachytherapy is not an Option[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 720-725.
[4] Buse Güler, Merve Çamlıbel, Samiye Mete. What Do Relatives of Turkish Women with Ovarian Cancer Share on Websites? : A Qualitative Research[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 732-738.
[5] Wook Youn Kim, Shin Hee Seo, Seung-Hyuk Shim, Jin Hee Park, Hyung Kyu Park, Kyeong A So, Tae Jin Kim, Sun Joo Lee. Correlation of immunohistochemistry and silver in situ hybridization for the assessment of c-MET in uterine cervical cancer patients treated with radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 745-752.
[6] John P. Micha, Howard D. Epstein, Michael C. Roossin, Randy Bohart, Mark A. Rettenmaier, Bram H. Goldstein. Neoadjuvant chemotherapy, radical hysterectomy and chemoradiation for stage iva cervical carcinoma[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 797-801.
[7] Yudi Mulyana Hidayat, Gatot Nyarumenteng Adhipurnawan Winarno, Maringan Diapari Lumban Tobing, Arieff Kustiandi, Kemala Isnainiasih Mantilidewi, Sofie Rifayani Krisnadi. The Role of Akt2 and CA-125 Serum Levels as Predictors for Successful Cytoreduction in Epithelial Ovarian Cancer Surgery[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 739-744.
[8] Juan Xu, Qingqing Tan, Ting Li. USP22 promotes the expression of GLUT1 and HK2 to facilitate growth and glycolysis in cervical cancer cells[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 790-796.
[9] Lingyun Zhai, Lixin Zeng, Hongru Jiang, Wei Li. Effects of a cyclooxygenase-1-selective inhibitor in combination with taxol or cisplatin on cyclin D1, apoptosis, and vascular endothelial growth factor in a xenograft model of ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 779-784.
[10] Yan qin Zhang, Di Wu, Meng qi Deng, Xiang yu Chang, Jin wei Miao, Yu mei Wu. Individual management of cervical cancer during pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 833-837.
[11] Qinglian Ma, Wenjie Yan, Jing Yang, Haiyan Wang, Weixiang Wang, Minghui Dong. Functional interpretation of ovarian cancer in correlation with ISGF3 expression pattern[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 769-773.
[12] Michelle F. Benoit, Kristy K. Ward. Uterine Cancer Normogram to Predict Lymph Node Metastasis: Comparison to the Mayo Algorithm and an External Validation of a Model in a North American Population[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 681-684.
[13] Yi-fan Luo, Li-xiang Ren, Ming-yan Jiang, Yang Chu. A systematic review and meta-analysis on the effects of metformin on survival outcomes and risk in women with cervical cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 504-507.
[14] Liman Yang, Jing Jin, Juhong Liu. Correlation of MMP2-C1306T (rs243865) and MMP7-181A/G (rs11568818) with cervical cancer: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 508-512.
[15] Silvia Ortega, José Angel Mínguez, José Manuel Aramendía, Marta Santisteban, Fernando Martinez-Regueira, Pablo Martí-Cruchaga, Juan Luis Alcázar, Matías Jurado. The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 523-530.
No Suggested Reading articles found!